Sequencing data from the Sanger and Broad Institutes indicated that none of these cancer cell lines displayed a mutation in ATRX or DAXX (Tate et al, 2019), except NOS1 that had a homozygous loss of the ATRX genes (Loo et al, 2010). This evidence concerns the gene DAXX and cancer.